Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Tvardi Therapeutics Inc’s stock clocked out at $24.61, down -2.38% from its previous closing price of $25.21. In other words, the price has decreased by -$2.38 from its previous closing price. On the day, 0.51 million shares were traded. TVRD stock price reached its highest trading level at $25.5921 during the session, while it also had its lowest trading level at $23.89.
Ratios:
To gain a deeper understanding of TVRD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 31.73 and its Current Ratio is at 32.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on June 12, 2025, initiated with a Overweight rating and assigned the stock a target price of $78.
On May 21, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $65.
On May 15, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $55.BTIG Research initiated its Buy rating on May 15, 2025, with a $55 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 28 ’25 when Posner Christopher sold 583 shares for $4.75 per share. The transaction valued at 2,769 led to the insider holds 13,109 shares of the business.
Terrillion Scott sold 163 shares of TVRD for $776 on Feb 28 ’25. The SEC’Y; CHIEF COMPLIANCE & G.C. now owns 7,190 shares after completing the transaction at $4.76 per share. On Feb 04 ’25, another insider, Posner Christopher, who serves as the PRESIDENT AND CEO of the company, sold 372 shares for $4.72 each. As a result, the insider received 1,756 and left with 13,692 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVRD now has a Market Capitalization of 230371760. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.43.
Stock Price History:
The Beta on a monthly basis for TVRD is 0.22, which has changed by 1.5992818 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, TVRD has reached a high of $34.31, while it has fallen to a 52-week low of $8.13. The 50-Day Moving Average of the stock is -3.63%, while the 200-Day Moving Average is calculated to be 54.12%.
Shares Statistics:
It appears that TVRD traded 48.08K shares on average per day over the past three months and 149150 shares per day over the past ten days. A total of 9.36M shares are outstanding, with a floating share count of 6.34M. Insiders hold about 32.22% of the company’s shares, while institutions hold 2.26% stake in the company.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
